Tuesday 11 August 2020

Should we worry about residual disease after mastectomy?



by Orit Kaidar-Person, Thorsten Kühn, Philip Poortmans 

The Lancet Oncology: volume 21, issue 8, p1001-1013. August 01, 2020

Breast cancer is the most frequently diagnosed cancer in women, accounting for 30% of new cancer cases, and leads to the highest proportion (15%) of cancer deaths.1 Surgical resection is the cornerstone of treatment with curative intent for patients with non-metastatic breast cancer, within comprehensive treatment from an integrated multidisciplinary team. The aim of resection is to remove all neoplastic tissue in the breast (both invasive cancer and ductal carcinoma in situ [DCIS]), to reduce the risk of further disease spread, including local and distant recurrence.

Please advise the Library desk if you would like full text access to this article